checkAd

     101  0 Kommentare Knight Therapeutics Inc. Celebrates its First Decade of Success - Seite 3

    CONTACT INFORMATION FOR KNIGHT:

    Investor Contact:  
    Knight Therapeutics Inc.  
    Samira Sakhia Arvind Utchanah
    President & Chief Executive Officer Chief Financial Officer
    T: 514.484.4483 T. +598.2626.2344
    F: 514.481.4116  
    Email: IR@knighttx.com Email: IR@knighttx.com
    Website: www.knighttx.com Website: www.knighttx.com

    1 Represents the sum of net income from 2014 to 2018 and adjusted EBITDA from 2019 to Q3-23 YTD

    Lesen Sie auch

     


    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Knight Therapeutics Inc. Celebrates its First Decade of Success - Seite 3 MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) - Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of expansion …